115 related articles for article (PubMed ID: 10376464)
1. Value of brush border cytology for dominant strictures in primary sclerosing cholangitis.
Stiehl A
Endoscopy; 1999 May; 31(4):333-4. PubMed ID: 10376464
[No Abstract] [Full Text] [Related]
2. Value of brush cytology for dominant strictures in primary sclerosing cholangitis.
Ponsioen CY; Vrouenraets SM; van Milligen de Wit AW; Sturm P; Tascilar M; Offerhaus GJ; Prins M; Huibregtse K; Tytgat GN
Endoscopy; 1999 May; 31(4):305-9. PubMed ID: 10376457
[TBL] [Abstract][Full Text] [Related]
3. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
5. A case of intrahepatic cholangiocarcinoma associated with primary sclerosing cholangitis.
Kanemitsu E; Esaki M
Jpn J Clin Oncol; 2010 Jun; 40(6):600. PubMed ID: 20508074
[No Abstract] [Full Text] [Related]
6. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis.
Lindberg B; Arnelo U; Bergquist A; Thörne A; Hjerpe A; Granqvist S; Hansson LO; Tribukait B; Persson B; Broomé U
Endoscopy; 2002 Nov; 34(11):909-16. PubMed ID: 12430077
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation.
Boberg KM; Jebsen P; Clausen OP; Aabakken L; Brekke I; Schrumpf E
J Hepatol; 2003 Sep; 39(3):453. PubMed ID: 12927935
[No Abstract] [Full Text] [Related]
9. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
Cheifetz RE; Davis NL; Owen DA
Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
Baskin-Bey ES; Moreno Luna LE; Gores GJ
J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574
[No Abstract] [Full Text] [Related]
11. Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels.
Furmanczyk PS; Grieco VS; Agoff SN
Am J Clin Pathol; 2005 Sep; 124(3):355-60. PubMed ID: 16191503
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
[TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
Layfield LJ; Cramer H
Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
[TBL] [Abstract][Full Text] [Related]
14. Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis.
Caldwell SH; Bickston SJ
Liver Transpl; 2001 Apr; 7(4):380. PubMed ID: 11303302
[No Abstract] [Full Text] [Related]
15. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?
de Groen PC
Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754
[No Abstract] [Full Text] [Related]
17. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
Linder S; Söderlund C
Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma associated with hypercalcaemia and ascites presenting as sclerosing cholangitis.
D'Costa DF
Br J Clin Pract; 1994; 48(4):217-8. PubMed ID: 7917805
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis.
Lazaridis KN
Hepatology; 2008 Jan; 47(1):8-10. PubMed ID: 18161699
[No Abstract] [Full Text] [Related]
20. Erratum: NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38727679
[No Abstract] [Full Text] [Related]
[Next] [New Search]
